% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Meroni:271104,
author = {Meroni, Marica and De Caro, Emilia and Chiappori, Federica
and Longo, Miriam and Paolini, Erika and Mosca, Ettore and
Merelli, Ivan and Lombardi, Rosa and Badiali, Sara and
Maggioni, Marco and Orro, Alessandro and Mezzelani,
Alessandra and Valenti, Luca and Fracanzani, Anna Ludovica
and Dongiovanni, Paola},
title = {{H}epatic and adipose tissue transcriptome analysis
highlights a commonly deregulated autophagic pathway in
severe {MASLD}},
journal = {Obesity},
volume = {32},
number = {5},
issn = {1071-7323},
address = {Hoboken, NJ},
publisher = {Wiley},
reportid = {DZNE-2024-00976},
pages = {923 - 937},
year = {2024},
abstract = {The incidence of metabolic dysfunction-associated steatotic
liver disease (MASLD) is rapidly ramping up due to the
spread of obesity, which is characterized by expanded and
dysfunctional visceral adipose tissue (VAT). Previous
studies have investigated the hepatic transcriptome across
MASLD, whereas few studies have focused on VAT.We performed
RNA sequencing in 167 hepatic samples from patients with
obesity and in a subset of 79 matched VAT samples.
Circulating cathepsin D (CTSD), a lysosomal protease, was
measured by ELISA, whereas the autophagy-lysosomal pathway
was assessed by Western blot in hepatic and VAT samples (n =
20).Inflammation, extracellular matrix remodeling, and
mitochondrial dysfunction were upregulated in severe MASLD
in both tissues, whereas autophagy and oxidative
phosphorylation were reduced. Tissue comparative analysis
revealed 13 deregulated genes, including CTSD, which showed
the most robust diagnostic accuracy in discriminating mild
and severe MASLD. CTSD expression correlated with
circulating protein, whose increase was further validated in
432 histologically characterized MASLD patients, showing a
high accuracy in foreseeing severe liver injury. In
addition, the assessment of serum CTSD increased the
performance of fibrosis 4 in diagnosing advanced disease.By
comparing the hepatic and VAT transcriptome during MASLD, we
refined the concept by which CTSD may represent a potential
biomarker of severe disease.},
cin = {AG Aschenbrenner},
ddc = {610},
cid = {I:(DE-2719)5000082},
pnm = {354 - Disease Prevention and Healthy Aging (POF4-354)},
pid = {G:(DE-HGF)POF4-354},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:38439203},
doi = {10.1002/oby.23996},
url = {https://pub.dzne.de/record/271104},
}